Citation Impact
Citing Papers
Staphylococcus aureus Throat Colonization Is More Frequent than Colonization in the Anterior Nares
2006
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Alteration of enzyme specificity by computational loop remodeling and design
2009 StandoutNobel
Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions
2000
“Pulse” Nasal Mupirocin Maintenance Regimen in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis
1999
Rheumatoid arthritis
2016 Standout
Paraquat Poisonings: Mechanisms of Lung Toxicity, Clinical Features, and Treatment
2007 Standout
Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use: A prospective study
2000 Standout
Prevention of Staphylococcus aureus infections among surgical patients: Beyond traditional perioperative prophylaxis
2003
Carbamylation and antibodies against carbamylated proteins in autoimmunity and other pathologies
2013
Preventing Surgical-Site Infections in Nasal Carriers of Staphylococcus aureus
2010
Effectiveness of Chlorhexidine Bathing to Reduce Catheter-Associated Bloodstream Infections in Medical Intensive Care Unit Patients
2007 Standout
The nose: an underestimated source of Staphylococcus aureus causing wound infection
1998
Metabonomics: a platform for studying drug toxicity and gene function
2002 Standout
Metabolic changes in schizophrenia and human brain evolution
2008 StandoutNobel
Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts
2007 Standout
Persistent (not intermittent) nasal carriage ofStaphylococcus aureus is the determinant of CPD-related infections
2005
Oral chemotherapy: rationale and future directions.
1998
Nasal Carriage of Staphylococcus aureus and Prevention of Nosocomial Infections
2005
Pattern recognition analysis of high resolution 1H NMR spectra of urine. A nonlinear mapping approach to the classification of toxicological data
1990
Equine Metabolic Syndrome
2010 Standout
Topical Antibacterial Agents
2009
INFECTIONS IN PATIENTS UNDERGOING PERITONEAL DIALYSIS
2001
Reduced Costs for Staphylococcus aureus Carriers Treated Prophylactically with Mupirocin and Chlorhexidine in Cardiothoracic and Orthopaedic Surgery
2012
Oral fluid collection: The neglected variable in oral fluid testing
2005
Testing for drugs of abuse in saliva and sweat
1998
The role of nasal carriage in Staphylococcus aureus infections
2005 Standout
Implant infections: adhesion, biofilm formation and immune evasion
2018 Standout
5-Fluorouracil: mechanisms of action and clinical strategies
2003 Standout
Clinical Pharmacology of 5-Fluorouracil
1989 Standout
Infection with Antimicrobial‐resistant Microorganisms in Dialysis Patients
2003
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
Human Cannabinoid Pharmacokinetics
2007 Standout
INFECTIONS ASSOCIATED WITH UREMIA AND DIALYSIS
2001
Nuclear Magnetic Resonance Spectroscopy: A Non-Invasive Probe of Kidney Metabolism and Function
1998
Global metabolic profiling procedures for urine using UPLC–MS
2010 Standout
The human skin microbiome
2018 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Candida Infections of Medical Devices
2004 Standout
Urinary proton magnetic resonance studies of early ifosfamide-induced nephrotoxicity and encephalopathy.
1997
Clinical practice guidelines for antimicrobial prophylaxis in surgery
2013 Standout
Current Status of Platinum-Based Antitumor Drugs
1999 Standout
Analysis of fetal and neonatal urine using proton nuclear magnetic resonance spectroscopy.
1995
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
The influence of cimetidine on the pharmacokinetics of 5‐fluorouracil.
1984
Nonlinear pharmacokinetics for the elimination of 5-fluorouracil after intravenous administration in cancer patients
1982
Pharmacokinetics of metformin after intravenous and oral administration to man
1979
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
NMR-Based Metabolic Profiling and Metabonomic Approaches to Problems in Molecular Toxicology
2008
Paraquat-induced renal injury studied by 1H nuclear magnetic resonance spectroscopy of urine
1998
Targeted Intranasal Mupirocin To Prevent Colonization and Infection by Community-Associated Methicillin-Resistant Staphylococcus aureus Strains in Soldiers: a Cluster Randomized Controlled Trial
2007
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
Prosthetic Joint Infection
2014 Standout
Nonlinear pharmacokinetic characteristics of 5-fluorouracil (5-FU) in colorectal cancer patients
1987
Intranasal Mupirocin does not Prevent Exit-Site Infections in Children Receiving Peritoneal Dialysis
2003
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update
2020 Standout
Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers
2008
Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter
1998
Effect of human renal and hepatic disease on the pharmacokinetics of anticancer drugs
1982
Works of M.R. Bending being referenced
Nasal Mupirocin Prevents Staphylococcus Aureus Exit-Site Infection During Peritoneal Dialysis
1996
Carbamylated Haemoglobin, Urea Kinetic Modelling and Adequacy of Dialysis in Haemodialysis Patients
1991
Acute Renal Failure Following Accidental Cutaneous Absorption of Phenol: Application of NMR Urinalysis to Monitor the Disease Process
1989
Drug concentration in saliva
1978
Plasma levels of 5‐fluorouracil after oral and intravenous administration in cancer patients.
1979